Literature DB >> 16343572

New initiatives against Africa's worms.

Alan Fenwick1.   

Abstract

Since 1999, the funding available for the control of diseases of poverty (neglected diseases) has increased mainly due to leverage resulting from donations by the Bill and Melinda Gates Foundation and loans from the World Bank. Many countries have embarked on control programmes on a national scale due to drug donations by pharmaceutical companies through vertical programmes. The Schistosomiasis Control Initiative has expanded its operations to cover six countries in sub-Saharan Africa, but overlap of treatments between different vertical programmes is now a reality, and so care is needed to ensure that too many different drugs are not given together. Dialogue between programme managers has increased, and integration of some programmes may offer chances of synergy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16343572     DOI: 10.1016/j.trstmh.2005.03.014

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  41 in total

1.  Environmental effects on parasitic disease transmission exemplified by schistosomiasis in western China.

Authors:  Song Liang; Edmund Y W Seto; Justin V Remais; Bo Zhong; Changhong Yang; Alan Hubbard; George M Davis; Xueguang Gu; Dongchuan Qiu; Robert C Spear
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-16       Impact factor: 11.205

2.  Modeling the effect of chronic schistosomiasis on childhood development and the potential for catch-up growth with different drug treatment strategies promoted for control of endemic schistosomiasis.

Authors:  David Gurarie; Xiaoxia Wang; Amaya L Bustinduy; Charles H King
Journal:  Am J Trop Med Hyg       Date:  2011-05       Impact factor: 2.345

Review 3.  Parasites and poverty: the case of schistosomiasis.

Authors:  Charles H King
Journal:  Acta Trop       Date:  2009-12-04       Impact factor: 3.112

Review 4.  Helminth infections: the great neglected tropical diseases.

Authors:  Peter J Hotez; Paul J Brindley; Jeffrey M Bethony; Charles H King; Edward J Pearce; Julie Jacobson
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

5.  Interference with hemozoin formation represents an important mechanism of schistosomicidal action of antimalarial quinoline methanols.

Authors:  Juliana B R Corrêa Soares; Diego Menezes; Marcos A Vannier-Santos; Antonio Ferreira-Pereira; Giulliana T Almeida; Thiago M Venancio; Sergio Verjovski-Almeida; Vincent K Zishiri; David Kuter; Roger Hunter; Timothy J Egan; Marcus F Oliveira
Journal:  PLoS Negl Trop Dis       Date:  2009-07-14

6.  Treatment of intestinal schistosomiasis in Ugandan preschool children: best diagnosis, treatment efficacy and side-effects, and an extended praziquantel dosing pole.

Authors:  José Carlos Sousa-Figueiredo; Joyce Pleasant; Matthew Day; Martha Betson; David Rollinson; Antonio Montresor; Francis Kazibwe; Narcis B Kabatereine; J Russell Stothard
Journal:  Int Health       Date:  2010-06       Impact factor: 2.473

7.  Which new approaches to tackling neglected tropical diseases show promise?

Authors:  Jerry M Spiegel; Shafik Dharamsi; Kishor M Wasan; Annalee Yassi; Burton Singer; Peter J Hotez; Christy Hanson; Donald A P Bundy
Journal:  PLoS Med       Date:  2010-05-18       Impact factor: 11.069

8.  Considerations for the design and conduct of a pharmacovigilance study involving mass drug administration in a resource-constrained setting.

Authors:  Demissie Alemayehu; Emma N Andrews; Paul Glue; Charles A Knirsch
Journal:  PLoS Negl Trop Dis       Date:  2010-01-26

9.  Social sciences research in neglected tropical diseases 1: the ongoing neglect in the neglected tropical diseases.

Authors:  Pascale Allotey; Daniel D Reidpath; Subhash Pokhrel
Journal:  Health Res Policy Syst       Date:  2010-10-21

10.  Neglected tropical diseases in sub-saharan Africa: review of their prevalence, distribution, and disease burden.

Authors:  Peter J Hotez; Aruna Kamath
Journal:  PLoS Negl Trop Dis       Date:  2009-08-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.